Hepatitis: Clinical Trials

397 trials for Hepatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

397 completed. 397 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4397Completed 397

Follow Hepatitis: new trials by email Literature Review of Hepatitis trials Research Report on Hepatitis

Trials (filtered) newest first · largest first

All 397 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
2 doses of HAV, At least one dose of HAV - Hepatitis A, Immunodeficiency
Phase 4CompletedLiuZhou People's Hospital3922023-12-192025-12-31
Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
Vemliver tablet, Baracross Tablet - Hepatitis B, Chronic
Phase 4CompletedDaewoong Pharmaceutical Co. LTD.1962023-08-282025-03-18
The COMBAT HBV Feasibility Trial
Tenofovir Disoproxil Fumarate 300 MG, Hepatitis B monovalent vaccine, Placebo - Hepatitis B, Vertical Transmission of Infectious Disease
Phase 4CompletedUniversity of North Carolina, Chapel Hill3152023-08-172026-11-16
Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above
Thiomersal-free Recombinant Hepatitis E Vaccine (Escherichia Coli), Recombinant Hepatitis E Vaccine (Escherichia Coli) - Hepatitis E
Phase 4CompletedXiamen Innovax Biotech Co., Ltd6122023-03-222024-08-21
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
DA-2803, DA-2803-R, Placebo of DA-2803 - Hepatitis B
Phase 4CompletedDong-A ST Co., Ltd.1202023-03-202024-10-23
Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%
Xpert HCV Viral load finger stick point of care test (Cepheid), Epclusa 400Mg-100Mg Tablet, Standard of care - Hepatitis C
Phase 4CompletedMacfarlane Burnet Institute for Medical Research and Public Health Ltd6062022-07-252023-11-13
The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF
Ergocalciferol Capsules, Calcium carbonate - Parathyroid Hormone, Tenofovir Disoproxil Fumarate
Phase 4CompletedMahidol University642022-05-012024-09-05
Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B
Stop group - Hepatitis B, Chronic
Phase 4CompletedAsan Medical Center1402021-09-012026-08-04
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal 13-valent conjugate vaccine - Diphtheria
Phase 4CompletedGlaxoSmithKline5002021-05-262024-08-27
Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders
Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin, Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] - Chronic Hepatitis C
Phase 4CompletedHelwan University2812020-11-212022-09-02
Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors
Glecaprevir/pibrentasvir - End Stage Renal Disease, Hepatitis C
Phase 4CompletedJohns Hopkins University102020-11-202024-01-10
HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial
Velpatasvir/Sofosbuvir - Hepatocellular Carcinoma, Hepatitis C
Phase 4CompletedAlexandria University842020-10-052023-04-04
HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders
Recombinant hepatitis B vaccine with CpG adjuvant - Healthcare Worker, Hepatitis B Vaccine, Nonresponder
Phase 4CompletedUniversity of Wisconsin, Madison492020-09-152024-07-16
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
Mavyret - Hepatitis C, Kidney Transplant; Complications
Phase 4CompletedMayo Clinic2272020-09-102026-10-29
The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study
Epclusa (SOF/VEL), Standard of care, Fibroscan® 430 Mini Plus - Hepatitis C, Chronic
Phase 4CompletedUniversity of California, San Francisco872020-07-012025-05-28
Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District
Engerix-B - Hepatitis B Virus, Health Care Associated Infection
Phase 4CompletedCentre for Infectious Disease Research in Zambia6412019-11-252026-08-10
The Kentucky Viral Hepatitis Treatment Study
Sofosbuvir/velpatasvir (Epclusa®) - Hepatitis C, Opioid-Related Disorders
Phase 4CompletedJennifer Havens3802019-09-232026-10-20
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier] - Hepatitis C, Hemodialysis
Phase 4CompletedUniversity of Pennsylvania62019-09-222021-12-15
Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum
Tenofovir disoproxil fumarate, Historical Data - Chronic Hepatitis B Infection
Phase 4CompletedMylan (Taiwan) Ltd402019-08-212022-05-02
Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC
Birth dose hepatitis B vaccine - Hepatitis B
Phase 4CompletedUniversity of North Carolina, Chapel Hill5692019-08-202021-03-03

Showing 20 of 397. Sign in to see all of them.

Narrower conditions

Hepatitis C (109)  ·  Hepatitis C, Chronic (100)  ·  Hepatitis B (98)  ·  Hepatitis B, Chronic (85)  ·  Hepatitis A (23)  ·  HIV Infections (22)  ·  Diphtheria (10)  ·  Fibrosis (10)  ·  Tetanus (10)  ·  Acquired Immunodeficiency Syndrome (9)  ·  Haemophilus Infections (8)  ·  Hepatitis E (7)  ·  Hepatitis, Chronic (7)  ·  Liver Cirrhosis (7)

Broader conditions

Digestive System Diseases (396)  ·  Liver Diseases (391)  ·  Virus Diseases (380)  ·  Hepatitis, Viral, Human (379)  ·  Infections (379)  ·  Blood-Borne Infections (363)  ·  Communicable Diseases (362)  ·  RNA Virus Infections (231)  ·  Pathological Conditions, Signs and Symptoms (211)  ·  Pathologic Processes (210)  ·  Disease Attributes (201)  ·  Chronic Disease (193)  ·  Flaviviridae Infections (188)  ·  Hepatitis, Chronic (184)

Interventions

Ribavirin (106)  ·  peginterferon alfa-2a (96)  ·  Tenofovir (33)  ·  entecavir (25)  ·  Sofosbuvir (23)  ·  Lamivudine (20)  ·  Hepatitis B Vaccines (18)  ·  peginterferon alfa-2b (18)  ·  Hepatitis A Vaccines (17)  ·  Engerix-B (14)  ·  ledipasvir, sofosbuvir drug combination (14)  ·  adefovir dipivoxil (13)  ·  Telbivudine (12)  ·  sofosbuvir-velpatasvir drug combination (12)  ·  adefovir (10)

Sponsors

GlaxoSmithKline (43)  ·  Hoffmann-La Roche (42)  ·  National Taiwan University Hospital (10)  ·  Kirby Institute (8)  ·  Merck Sharp & Dohme LLC (7)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (6)  ·  Novartis Pharmaceuticals (6)  ·  Xiamen Innovax Biotech Co., Ltd (6)  ·  Bukwang Pharmaceutical (5)  ·  University of California, San Francisco (5)  ·  University of Maryland, Baltimore (5)  ·  University of North Carolina, Chapel Hill (5)  ·  Asan Medical Center (4)  ·  Brooke Army Medical Center (4)  ·  Foundation for Liver Research (4)

Countries

United States (89)  ·  China (51)  ·  South Korea (40)  ·  Taiwan (29)  ·  Germany (28)  ·  Canada (24)  ·  Spain (20)  ·  Australia (18)  ·  Belgium (18)  ·  Thailand (18)  ·  Brazil (16)  ·  France (11)  ·  Italy (11)  ·  Sweden (11)  ·  United Kingdom (10)

Top investigators

Chen-Hua Liu, MD (6)  ·  Ming-Lung Yu, MD, PhD (5)  ·  Cheng-Chao Liang, MD (3)  ·  Ding-Shinn Chen, MD (3)  ·  Hong You, Doctor (3)  ·  Jee-Fu Huang, MD (3)  ·  Jia-Horng Kao, MD, PhD (3)  ·  Jun Yong Park, M.D (3)  ·  Sang Hoon Ahn, M.D.Ph.D (3)

Results publications

PMID 32710245, PMID 20009522, PMID 21366801, PMID 22508412, PMID 22777097, PMID 23732904, PMID 24508042, PMID 24915612, PMID 26190091, PMID 26867206, PMID 30689258, PMID 35599306, PMID 37096802, PMID 39373164, PMID 10618544, PMID 11850253, PMID 11984144, PMID 12375147, PMID 15014185, PMID 15191208, PMID 15470215, PMID 15750456, PMID 16183464, PMID 16391218, PMID 16530509, PMID 1665400, PMID 16673294, PMID 17239478, PMID 17259872, PMID 17302380, PMID 17484872, PMID 17625124, PMID 17875007, PMID 17935165, PMID 17943989, PMID 18081737, PMID 18508296, PMID 18541174, PMID 18563054, PMID 18684176, PMID 18697216, PMID 18834319, PMID 19052131, PMID 19053049, PMID 19092267, PMID 19144941, PMID 19187608, PMID 19207973, PMID 19274046, PMID 19399802

NIH funding

2005 (3), 2004 (2), 2015 (2), 2016 (2), 2009 (1), 2014 (1), 2019 (1), K23DK082621 (1), R01DA013806 (1), R01DA014502 (1), R01DA016764 (1), R01DA033777 (1), R01DA047952 (1), R21DA016066 (1), U01AI115714 (1)